局部前列腺癌中度大分割放疗与传统分割剂量递增放疗后的白细胞减少:一项随机研究的二次分析
该研究为一项III期随机研究的二次分析,比较局部前列腺癌患者接受中度大分割(HYPO)与传统分割(CF)放疗期间白细胞计数的变化。共140例(83.3%)患者纳入分析,在剂量水平#3(中位剂量52 Gy)时,CF组平均白细胞计数为5397/mm³,HYPO组为6038/mm³,差异有统计学意义(p=0.004)。结论认为分次方式与治疗期间白细胞下降相关,HYPO优于CF。
要点
- 在剂量水平#3(中位52 Gy)时,CF组平均白细胞计数5397/mm³ vs HYPO组6038/mm³(p=0.004)。
- GLM模型显示HYPO组剂量对白细胞计数的影响显著低于CF组(Greenhouse-Geisser检验,p=0.04)。
- CF组白细胞计数在所有剂量水平均呈下降趋势,HYPO组仅在治疗早期部分下降。
核心结论
- 该III期研究的二次分析显示,分次方式与局部前列腺癌治疗期间白细胞下降相关,HYPO优于CF。
研究设计与样本
- 从一项比较HYPO与CF的III期随机研究病历中提取每周血检结果进行二次分析。
- 168例随机患者中140例(83.3%)在每个选定剂量水平至少有一次观察并被纳入分析。
- 根据递送剂量百分位数对白细胞计数分箱,确定中位剂量分别为16、34.1和52 Gy的三个剂量水平。
- 采用基于混合设计方差分析(ANOVA)的一般线性模型(GLM)检验两组间白细胞计数变异。
主要发现
- 在所有选定剂量水平,CF组平均白细胞计数均低于HYPO组。
- 在剂量水平#3达到统计学显著差异:CF组5397/mm³ vs HYPO组6038/mm³(p=0.004)。
- GLM模型确认HYPO组剂量对白细胞计数的影响显著低于CF组(Greenhouse-Geisser检验,p=0.04)。
- CF组白细胞计数在所有剂量水平均倾向下降,而HYPO组仅在治疗较早部分出现此情况。
关键数值与推荐
- 剂量水平#3中位剂量为52 Gy。
- 剂量水平#3白细胞计数:CF组5397/mm³ vs HYPO组6038/mm³(p=0.004)。
- GLM模型组间比较:Greenhouse-Geisser检验p=0.04。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To compare WBC counts during treatment of localized prostate cancer with either conventionally fractionated (CF) or moderately hypofractionated (HYPO) radiotherapy. METHODS: Weekly blood test results were extracted from the charts of patients treated within a phase III study comparing HYPO to CF. In order to compare WBC counts at the same nominal dose in both arms and thus to tease out the effect of fractionation, for each recorded WBC value the corresponding cumulative total dose was extracted as well. WBC counts were binned according to percentiles of the delivered dose and three dose levels were identified at median doses of 16, 34.1 and 52 Gy, respectively. A General Linear Model based on mixed design Analysis Of Variance (ANOVA) was used to test variation of WBC counts between the two treatment arms. RESULTS: Out of 168 randomized patients, 140 (83.3%) had at least one observation for each one of the selected dose levels and were included in the analysis. Mean counts were lower in the CF than the HYPO arm at all selected dose levels, reaching a statistically significant difference at dose level #3 (5397/mm3 vs 6038/mm3 for CF and HYPO, respectively, p = 0.004). The GLM model confirms that the impact of dose on WBC counts is significantly lower in the HYPO arm over the CF one (Greenhouse-Geisser test, p = 0.04). Interestingly, while WBC counts tend to drop throughout all dose levels in the CF arm, this is the case only in the earlier part of treatment in the HYPO arm. CONCLUSION: This secondary analysis of a phase III study shows that dose fractionation is correlated to WBC drop during treatment of localized prostate cancer, favoring HYPO over CF.
引用
- Sanguineti G, Giannarelli D, Petrongari MG, et al. Leukotoxicity after moderately Hypofractionated radiotherapy versus conventionally fractionated dose escalated radiotherapy for localized prostate Cancer: a secondary analysis from a randomized study. Radiat Oncol. 2019. PMID: 30700317. doi:10.1186/s13014-019-1223-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。